Table of Content

1. Introduction


2. Research Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Global Continuous Glucose Monitoring Market


6. Market Share – Global Continuous Glucose Monitoring Analysis

6.1 By Component
6.2 By End User
6.3 By Country


7. Component – Global Continuous Glucose Monitoring Market

7.1 Sensors
7.2 Transmitters
7.3 Receivers


8. End-User – Global Continuous Glucose Monitoring Market

8.1 Hospitals
8.2 Homecare Settings
8.3 Others


9. Countries – Global Continuous Glucose Monitoring Market

9.1 North America

9.1.1 United States
9.1.2 Canada

9.2 Europe

9.2.1 France
9.2.2 Germany
9.2.3 Italy
9.2.4 Spain
9.2.5 United Kingdom
9.2.6 Belgium
9.2.7 Netherlands
9.2.8 Turkey

9.3 Asia Pacific

9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 South Korea
9.3.5 Thailand
9.3.6 Malaysia
9.3.7 Indonesia
9.3.8 Australia
9.3.9 New Zealand

9.4 Latin America

9.4.1 Brazil
9.4.2 Mexico
9.4.3 Argentina

9.5 Middle East & Africa

9.5.1 Saudi Arabia
9.5.2 United Arab Emirates
9.5.3 South Africa

9.6 Rest of the World


10. CGM Reimbursement Policy


11. Porters Five Forces

11.1 Bargaining Power of Buyer
11.2 Bargaining Power of Supplier
11.3 Threat of New Entrants
11.4 Rivalry among Existing Competitors
11.5 Threat of Substitute Products


12. SWOT Analysis

12.1 Strengths
12.2 Weaknesses
12.3 Opportunities
12.4 Threats


13. Key Players Analysis

13.1 Dexcom Inc

13.1.1 Overview
13.1.2 Key Persons
13.1.3 Product Analysis
13.1.4 Recent Development
13.1.5 Revenue

13.2 Ypsomed AG

13.2.1 Overview
13.2.2 Key Persons
13.2.3 Product Analysis
13.2.4 Recent Development
13.2.5 Revenue

13.3 Abbott Laboratories

13.3.1 Overview
13.3.2 Key Persons
13.3.3 Product Analysis
13.3.4 Recent Development
13.3.5 Revenue

13.4 Senseonics Holdings, Inc.

13.4.1 Overview
13.4.2 Recent Development
13.4.3 Revenue

13.5 Nemaura Medical, Inc.

13.5.1 Overview
13.5.2 Key Persons
13.5.3 Product Analysis
13.5.4 Recent Development
13.5.5 Revenue

13.6 Medtronic, Inc.

13.6.1 Overview
13.6.2 Key Persons
13.6.3 Product Analysis
13.6.4 Recent Development
13.6.5 Revenue

13.7 Tandem Diabetes Care

13.7.1 Overview
13.7.2 Key Persons
13.7.3 Product Analysis
13.7.4 Recent Development
13.7.5 Revenue

13.8 Nova Biomedical

13.8.1 Overview
13.8.2 Key Persons
13.8.3 Product Analysis
13.8.4 Recent Development
13.8.5 Revenue